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Key Points 
MGUS patients have significantly increased cortical bone porosity and reduced bone 
strength relative to matched controls. 
 
Abstract 
Patients with monoclonal gammopathy of undetermined significance (MGUS) are at 
increased fracture risk, and we have previously shown that MGUS patients have altered 
trabecular bone microarchitecture compared with controls. However, there are no data on 
whether the porosity of cortical bone, which may play a greater role in bone strength and 
the occurrence of fractures, is increased in MGUS. Thus, we studied cortical porosity and 
bone strength (apparent modulus) using high-resolution peripheral quantitative computed 
tomography (HRpQCT) imaging of the distal radius in 50 MGUS patients and 100 age-, sex-, 
and BMI matched controls. Compared to controls, MGUS patients had both significantly 
higher cortical porosity (+16.8%; P<0.05) and lower apparent modulus ( ?8.9%; P<0.05). In 
conclusion, despite their larger radial bone size, MGUS patients have significantly increased 
cortical bone porosity and reduced bone strength relative to controls. This increased cortical 
porosity may explain the increased fracture risk seen in MGUS patients. 
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Introduction 
Population-based studies have shown that fracture risk is increased in MGUS.
1,2
 Previously,
3
 
we used high-resolution peripheral quantitative computed tomography (HRpQCT) imaging 
of the distal radius to demonstrate that MGUS patients have significantly altered trabecular 
bone microarchitecture, but also greater bone size relative to matched controls. However, 
the impact of these skeletal alterations on bone strength, which can be assessed from 
HRpQCT images using micro-ĨŝŶŝƚĞĞůĞŵĞŶƚ ?ʅ& ?ĂŶĂůǇƐŝƐ ?4 is unknown. Moreover, evidence 
suggests cortical bone porosity may be more important for bone strength and fracture risk 
than trabecular bone microarchitectural changes.
5,6 
 
Recent work demonstrates that the default HRpQCT cortical bone analysis previously 
utilized
3
 performs poorly for subjects with thin or porous cortices.
7
 Recognizing this 
limitation, Burghardt and colleagues
8
 developed a novel image processing protocol that 
automatically segments and quantifies cortical bone microarchitecture from HRpQCT 
images. This permits detection of intracortical pore space morphologically and provides a 
cortical porosity index shown to increase with age in men and women,
5
 enhancing 
identification of subjects at increased fracture risk.
6
 Notably, this technique has not yet 
been applied to patients with any hematologic condition. 
 
Therefore, we utilized novel advancements in ,ZƉYdŝŵĂŐĞƉƌŽĐĞƐƐŝŶŐĂŶĚʅ&analysis to 
determine whether MGUS patients have altered cortical bone microarchitecture and deficits 
in biomechanical bone strength compared to matched controls. 
 
Methods 
Subjects. After Mayo Clinic Institutional Review Board approval, subjects were recruited as 
previously described
3
 and written informed consent was obtained. Subjects included 50 
patients diagnosed with MGUS according to International Myeloma Working Group criteria
9
 
and 100 age-, sex-, and body mass index (BMI)-matched (1:2 ratio) controls from an age-
stratified random sample of Olmsted County, Minnesota, residents.
10
 Reflecting the local 
ethnic composition,
11
 97% of subjects were white. 
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Study protocol. All procedures were conducted at the Mayo Clinic outpatient Clinical 
Research Unit (Rochester, Minnesota). Anthropometic data were collected on all subjects. 
Bone microarchitecture and strength of the non-dominant distal radius were assessed by 
HRpQCT; data from 3 scans (1 MGUS/2 controls) were excluded because of motion artifact. 
 
HRpQCT imaging. Details regarding distal radial HRpQCT measurements and the default 
image analysis protocol have been described previously.
3
 In the present analysis, we used 
the recently developed extended cortical analysis
8
 to obtain cortical volumetric bone 
mineral density (vBMD, mg/cm
3
), cortical thickness (mm), cortical pore volume (mm
3
), and 
cortical porosity (%). 
 
ʅ&ĂŶĂůǇƐŝƐ ?>ŝŶĞĂƌʅ&ŵŽĚĞůƐǁĞƌĞĐƌĞĂƚĞĚĚŝƌĞĐƚůǇĨƌŽŵƚŚĞ,ZƉYdŝŵĂŐĞƐ ?ʅ&
element analysis solver v.1.15, Scanco Medical AG, Brüttisellen, Switzerland) as previously 
described.
12
 Biomechanical bone strength estimates (i.e., stiffness, failure load, apparent 
modulus) were derived from a uniaxial compression test simulating 1% compression, such 
that 2% of all elements had an effective strain >7000 microstrain. This test simulates a fall 
from standing ŚĞŝŐŚƚŽŶƚŚĞŽƵƚƐƚƌĞƚĐŚĞĚŚĂŶĚ ?ƚƌĂƵŵĂĐůĂƐƐŝĐĂůůǇĂƐƐŽĐŝĂƚĞĚǁŝƚŚŽůůĞƐ ?
fractures.
13
 Failure ůŽĂĚƐĐĂůĐƵůĂƚĞĚĨƌŽŵƐƵĐŚʅ&ŵŽĚĞůƐĐŽƌƌĞůĂƚĞŚŝŐŚůǇ ?ƌ = 0.87) with 
compressive loads ƉƌŽĚƵĐŝŶŐŽůůĞƐ ?Ĩƌactures in cadaveric forearms.4 
 
Statistical analysis. Comparisons of bone parameters between MGUS patients and controls 
were made using an analysis of variance model adjusted for age and sex. Testing was 
performed at a significance level of p<0.05 (two-tailed). 
 
Results and Discussion 
Figure 1A shows representative cross-sectional distal radius HRpQCT images (slice 55 of 
110) from a female MGUS patient (left) and an age-, sex-, and BMI-matched control subject 
(right), with the MGUS patient having both cortical thinning and deficits in cortical vBMD 
relative to the matched control. Further, MGUS was associated with higher cortical porosity, 
particularly along the medial and posterior borders of the distal radius. 
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Clinical characteristics and bone parameters of the MGUS and control groups (Table 1) 
demonstrates that the MGUS and control groups were similar in age, height, weight and 
BMI. MGUS patients had significantly higher cortical porosity (+16.8%; P<0.05; Figure 1B), 
tended to have higher cortical pore volumes (+15.5%; P=0.087), and had significant deficits 
in cortical volumetric bone mineral density ( ?4.5%; P<0.001) versus controls. Further, 
cortical thickness was lower ( ?6.6%) in MGUS patients, although this difference only 
approached significance (P=0.067). Biomechanical bone strength parameters (failure load, 
stiffness, and apparent modulus) were lower in MGUS patients (by  ?4.0%,  ?4.6%, and  ?
8.9%, respectively), although only the apparent modulus difference was statistically 
significant (P<0.05; Figure 1C). 
 
While MGUS patients are at increased risk for fracture1
,2 
and progression to multiple 
myeloma or a related plasma cell cancer,
14
 clinically, MGUS patients are followed without 
treatment until progression.
15
 In this study, we used HRpQCT aŶĚʅ&ĂŶĂůǇƐŝƐƚŽƐŚŽǁƚŚĂƚ 
MGUS patients have altered cortical microarchitecture and lower biomechanical bone 
strength versus matched controls, factors likely significant for explaining their increased 
fracture risk. 
 
Although dual-energy X-ray absorptiometry (DXA) is clinically used for monitoring skeletal 
health, it cannot separate trabecular from cortical bone, a shortcoming which limits its 
ability to detect changes within these skeletal compartments. An advantage of HRpQCT is 
that such separation is readily performed, and as indicated by our findings, HRpQCT imaging 
clearly demonstrates that MGUS is associated with significantly higher cortical porosity. 
Despite their larger radial bone size,
3
 MGUS patients had significantly lower cortical vBMD 
and tended to have thinner cortices relative to controls. These results extend our previous 
findings
3
 demonstrating altered trabecular microarchitecture with MGUS. 
 
ŶŽƚŚĞƌŶŽǀĞůĂƐƉĞĐƚŽĨŽƵƌĂŶĂůǇƐŝƐŝƐƚŚĞʅ&ŵŽĚĞůƐĐŽŶƐƚƌƵĐƚĞĚƚŽĂƐƐĞƐƐďŽŶĞ 
biomechanical properties in response to a simulated axial compression test.
4
 Our findings 
that failure load and stiffness both tended to be lower in MGUS patients are consistent with 
the suggestion that bone strength is reduced in MGUS. Notably, these deficits did not reach 
statistical significance, likely because of the compensatory increase in bone size seen in 
7 
 
MGUS patients,
3
 an increase likely resulting from progressive periosteal (outer surface) 
bone apposition with concomitantly increased endocortical (inner surface) resorption, 
ultimately resulting in cortical thinning. Such outward cortical displacement increases 
resistance to bending stresses, providing a partial biomechanical adaptation to limit the 
overall loss of bone strength resulting from decreased cortical thickness.
16
 Consistent with 
this premise, MGUS patients had significantly lower radial apparent modulus (bone strength 
corrected for cross-sectional area) compared to controls. 
 
The importance of cortical bone morphology in bone strength and fracture prevention is 
highlighted by observations that cortical bone comprises over 80% of the adult skeleton,
17
 
and that after age 65, most appendicular bone loss is cortical.
18
 Further, 80% of fractures 
after age 65 occur at predominantly cortical skeletal sites.
19
 Thus, the cortical bone 
deterioration we observed in MGUS patients is of significant clinical concern, and 
emphasizes the need for treatments that prevent such bone loss. 
 
A limitation of our study is that currently only cross-sectional data are available. Thus, long-
term consequences of the cortical bone abnormalities we observed in the MGUS patients 
remain unknown, although we plan to examine this question by longitudinally following this 
cohort. Another potential concern is that our HRpQCT measurements were limited to the 
radius. Lastly, future studies are necessary to determine whether the identified skeletal 
abnormalities are worse in patients with multiple myeloma or related plasma cell 
malignancies. 
 
In conclusion, despite their larger radial bone size, MGUS patients have compromised 
cortical microarchitecture (i.e., increased cortical bone porosity) and reduced bone strength 
relative to controls. Our findings underscore the need to further delineate the factors that 
regulate bone microarchitecture in MGUS, both to better identify those patients at greatest 
fracture risk and to develop therapies to limit MGUS-associated bone loss. 
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Tables 
Table 1. Clinical characteristics and distal radius bone parameters (derived using the extended cortical 
bone analysis and ȝFEA of HRpQCT images) in MGUS patients and matched control subjects 
 
 MGUS 
(n = 50) 
Control 
(n = 100) P 
Clinical characteristics    
Male; n (%) 30 (60%) 60 (60%)  
Age (yrs) 70.5 ± 1.4 70.3 ± 1.0 0.878 
Height (cm) 171 ± 1.5 170 ± 0.9 0.763 
Weight (kg) 82.2 ± 2.3 83.0 ± 1.6 0.789 
BMI (kg/m2) 28.2 ± 0.7 28.6 ± 0.4 0.622 
Cortical bone parameters (derived by HRpQCT)    
Cortical porosity (%) 2.91 ± 0.19 2.46 ± 0.13 0.048 
Cortical pore volume (mm3) 17.3 ± 1.2 14.8 ± 0.8 0.087 
Cortical volumetric BMD (mg/cm3) 907 ± 8.0 949 ± 5.7 <0.001 
Cortical thickness (mm) 0.990 ± 0.030 1.058 ± 0.021 0.067 
Biomechanical bone strength (derived by ȝFEA)    
Failure load (N) 4049 ± 112 4215 ± 79 0.230 
Stiffness (kN/mm) 80 ± 2.3 84 ± 1.6 0.189 
Apparent modulus (MPa) 1768 ± 67 1933 ± 47 0.045 
Values are presented as percentage or mean ± SE and P values. Comparisons of bone parameters are 
adjusted for age and sex. MGUS = monoclonal gammopathy of undetermined significance; BMI = body 
mass index; HRpQCT = high-resolution peripheral quantitative computed tomography; BMD = bone 
mineral density; ȝFEA = micro-finite element analysis. 
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Figure Legend: 
 
Figure 1. (A) Representative cross-sectional HRpQCT images of the distal radius (slice 55 of 
110) in a female MGUS patient (Left Panel) and an age-, sex-, and BMI-matched control 
subject (Right Panel). A = anterior; P = posterior; M = medial; L = lateral. (B) Cortical Porosity 
and (C) Apparent Modulus (bone strength corrected for cross-sectional area) at the distal 
radius in MGUS patients and controls. MPa = megapascal. Data are shown as mean ± SE 
adjusted for age and sex. *P<0.05 for difference between groups. 
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